Fig. 3From: Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinomaROC curve analysis of response to carboplatin/ paclitaxel based chemoradiation prediction by the differentially mutated genes in EAC. ROC curve shows high sensitivity and specificity for predicting response to chemoradiotherapy. A EPHA5 gene (B) BCL6 gene (C) ERBB2 gene (D) Combined 3-gene signatureBack to article page